June 12, 2025
All resources
Access a curated library of reports, policy submissions, data insights, and other materials informing Canada’s life sciences ecosystem.
Filter by
March 15, 2023
July 06, 2022
July 06, 2022
Developing a pan-Canadian genomics strategy: Innovative Medicines Canada response
IMC supports the creation of a Pan Canadian Genomics Strategy (PCGS) to help Canada advance its international leadership and increase capacity in genomics through commercialization and adoption.
August 20, 2020
August 20, 2020
IMC and BTC joint response to CADTH’s transparency consultation
IMC and and BIOTECanada write to Suzanne McGurn with joint input on the current CADTH process consultation.
March 06, 2020
March 06, 2020
Importation of prescription drugs; Proposed rule
IMC comments on the notice of proposed rulemaking titled “Importation of Prescription Drugs” published by the U.S. Food and Drug Administration in the Federal Register, December 23, 2019.
February 14, 2020
February 14, 2020
IMC response to PMPRB draft guidelines
IMC responds to PMPRB draft guidelines released November 21, 2019, stating a balance must be struck between budgetary pressures confronting Canadian governments and the preservation of Canadians’ timely access to life-saving innovative medicines.
